Antonio Drago; Barbara Monti; Diana De Ronchi; Alessandro Serretti, Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients., «NEUROPSYCHOBIOLOGY», 2014, 69, pp. 76 - 82 [Scientific article]
Eugenie Nepovimova;Elisa Uliassi;Jan Korabecny;Luis Emiliano Peña-Altamira;Sarah Samez;Alessandro Pesaresi;Gregory E. Garcia;Manuela Bartolini;Vincenza Andrisano;Christian Bergamini;Romana Fato;Doriano Lamba;Marinella Roberti;Kamil Kuca;Barbara Monti;Maria Laura Bolognesi, Multitarget Drug Design Strategy: Quinone–Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects, «JOURNAL OF MEDICINAL CHEMISTRY», 2014, 57, pp. 8576 - 8589 [Scientific article]
Emiliano Peña-Altamira; Elisabetta Polazzi; Edoardo Moretto; Mattia Lauriola; Barbara Monti, The transcription factor CCAAT enhancer-binding protein β protects rat cerebellar granule neurons from apoptosis through its transcription-activating isoforms., «EJN. EUROPEAN JOURNAL OF NEUROSCIENCE», 2014, 39, pp. 176 - 185 [Scientific article]
Sintoni S; Kurtys E; Scandaglia M; Contestabile A; Monti B., Chronic valproic acid administration impairs contextual memory and dysregulates hippocampal GSK-3β in rats., «PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR», 2013, 106, pp. 8 - 15 [Scientific article]
Polazzi E.; Mengoni I.; Caprini M.; Peña-Altamira E.; Kurtys E.; Monti B., Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity., «NEUROSIGNALS», 2013, 21, pp. 112 - 128 [Scientific article]
Peña-Altamira LE; Polazzi E; Monti B., Histone post-translational modifications in Huntington's and Parkinson's diseases., «CURRENT PHARMACEUTICAL DESIGN», 2013, 19, pp. 5065 - 5075 [Scientific article]
Monti B., Histone post-translational modifications to target memory-related diseases., «CURRENT PHARMACEUTICAL DESIGN», 2013, 19, pp. 5065 - 5075 [Scientific article]
Michela Rosini; Elena Simoni; Manuela Bartolini; Elena Soriano; José Marco-Contelles; Vincenza Andrisano; Barbara Monti; Manfred Windisch; Birgit Hutter-Paier; David W. McClymont; Ian R. Mellor; Maria Laura Bolognesi, The bivalent ligand approach as a tool for improving the in vitro anti-Alzheimer multitarget profile of dimebon, «CHEMMEDCHEM», 2013, 8, pp. 1276 - 1281 [Scientific article]
Contestabile A.; Sintoni S.; Monti B., Histone Deacetylase (HDAC) Inhibitors as Potential Drugs to Target Memory and Adult Hippocampal Neurogenesis, «CURRENT PSYCHOPHARMACOLOGY», 2012, 1, pp. 14 - 28 [Scientific article]
Contestabile A; Monti B; Polazzi E., Neuronal-glial Interactions Define the Role of Nitric Oxide in Neural Functional Processes, «CURRENT NEUROPHARMACOLOGY», 2012, 10, pp. 303 - 310 [Scientific article]
Monti B.; Mercatelli D.; Contestabile A., Valproic acid neuroprotection in 6-OHDAlesioned rat, a model for parkinson's disease, «HOAJ BIOLOGY», 2012, 1, pp. 1 - 4 [Scientific article]
Polazzi E.; Monti B., Microglia and neuroprotection: from in vitro studies to therapeutic applications., «PROGRESS IN NEUROBIOLOGY», 2010, 92 (3), pp. 293 - 315 [Scientific article]
Monti B.; Gatta V.; Piretti F.; Raffaelli S.; Virgili M.; Contestabile A., Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha synuclein, «NEUROTOXICITY RESEARCH», 2010, 17, pp. 130 - 141 [Scientific article]
Monti B.; Polazzi E.; Contestabile A., Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection, «CURRENT MOLECULAR PHARMACOLOGY», 2009, 2, pp. 95 - 109 [Scientific article]
Eleuteri S.; Monti B.; Brignani S.; Contestabile A., Chronic dietary administration of valproic acid protects neurons of the rat nucleus basalis magnocellularis from ibotenic acid neurotoxicity, «NEUROTOXICITY RESEARCH», 2009, 15, pp. 127 - 132 [Scientific article]
